Life Sciences - Page 40 - Research Triangle Regional Partnership

Flush with $22M, newly merged 9 Meters Biopharma launches in Raleigh with focus on GI diseases

May 1, 2020

RALEIGH — Introducing 9 Meters Biopharma, the new company birthed from the merger of Raleigh-based Innovate Biopharmaceuticals, a clinical stage…

Durham’s Chimerix gets FDA nod to test cancer drug in COVID-19 patients

April 30, 2020

DURHAM — Chimerix has gotten the green light to test an investigational cancer drug to treat COVID-19 patients. The Durham-based…

Gene therapy firm AskBio acquires French company targeting deadly brain disease

April 22, 2020

RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio), a clinical stage gene therapy company in Research Triangle Park, has acquired BrainVectis,…

Raleigh pharma to have second drug tested for potential COVID-19 treatment

April 21, 2020

With fresh data from existing trials treating COVID-19 patients in Italy and Israel, a Triangle drugmaker has announced a deal…

RedHill Biopharma, which has US HQ in Raleigh, pursues second COVID-19 treatment

April 21, 2020

RALEIGH – RedHill Biopharma is another step closer to getting one of its potential treatments for COVID-19 tested. The Israeli…

LabCorp receives FDA approval to sell at-home COVID-19 test

April 21, 2020

BURLINGTON – Health services giant LabCorp will begin selling an at-home test for the COVID-19 virus after receiving emergency authorization…

RTP nutrition startup lands $5M in funding; Hatteras, Launch Place among backers

April 20, 2020

RESEARCH TRIANGLE PARK – Panaceutics Nutrition, a provider of personalized nutrition products with operations in Research Triangle Park, has closed…

UNC scientists unravel some of schizophrenia’s secrets through genome sequencing

April 19, 2020

CHAPEL HILL – Most research about the genetics of schizophrenia has sought to understand the role that genes play in…

NSF seeks proposals for $200M in federal grants – here’s how to apply

April 13, 2020

Research and development goes on despite the COVID-19 pandemic with a new funding cycle beginning for federal grants. The National…